Five years ago the NFL pledged $30 million to the National Institutes of Health to help fund a new Sports and Health Research Program to advance brain research.
Since then, studies surfaced accusing the NFL of attempting to improperly influence government research by steering money away from a neuroscientist who had been critical of the league’s head injury protocol and trying to steer the investigation toward a physician with ties to the NFL. The NFL rejected the study findings.
According to the LA Times, ESPN reported that in wake of the allegations, NIH will walk away from $16 million of the committed amount.
The NIH said in a statement Thursday that there are “no current research plans” for the remaining funds; however, the NFL said league officials are discussing research projects with the fundraising arm of the NIH, according to the report.
More articles on healthcare finance:
6 recent grants, donations to healthcare organizations
10 hospitals seeking RCM talent
6 recent hospital, health system outlook and credit rating actions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
